Fludeoxyglucose (18F) clinical trials
3 indexed studies · 0 currently recruiting
- Ongoing, recruitingTherapeutic exploratory (Phase II)
68Ga-FAPI PET/CT: The Diagnostic Accuracy for Primary Staging and Re-staging after Chemotherapy in Patients with Gastric and Gastro-esophageal Junctional Cancer
This study is looking at new ways to scan people with stomach or food pipe cancer. It compares two types of special scans (FAPI PET/CT and FDG PET/CT) to see which one is better at finding cancer and checking how well treatments are working. The aim is to improve how doctors understand and treat these cancers.
For: Gastroesophageal junction cancer (GEJ-cancer), Gastric cancerDenmark - Ongoing, recruitingPhase II and Phase III (Integrated)
FDG-PET/CT versus conventional CT for response monitoring in metastatic breast cancer: A pilot study for a randomized clinical trial (MONITOR-PILOT)
This study looks at different scans for people with advanced breast cancer. It compares standard CT scans with a special FDG-PET/CT scan to see which better shows how well treatment is working and if it helps people live longer and have a better quality of life.
For: Metastatic breast cancerDenmark - Ongoing, recruitingTherapeutic exploratory (Phase II)
68Ga-FAPI PET/CT: The Diagnostic Accuracy for Primary Staging and Re-staging of Patients with Ovarian Cancer
This study compares two types of body scans (FAPI PET/CT and FDG PET/CT) to see which is better at finding and monitoring ovarian cancer. It aims to improve how doctors understand the cancer's spread and track treatment results.
For: Ovarian CancerDenmark